Key words: chemokine; eosinophilia; eotaxin; interstitium; renal disease Background. A potent eosinophil chemotactic cytokine, human eotaxin, is directly chemotactic for eosinophils. Therefore, the specific expression of eotaxin in tissue might play a crucial role in tissue eosinophilia.
gated the relationship between eotaxin levels and dis-(MCAF )/monocyte chemotactic protein (MCP)-1, IL-8, ease activity. platelet basic protein, platelet factor 4, regulated upon activation, normal T-cell expression and secreted (RANTES ). The recovery rate was confirmed to be >95% up to 3 ng/ml in Subjects and methods these ELISA systems. All assays were performed in duplicate. The detection limit of this ELISA system was 100 pg/ml for In this study, we evaluated 20 healthy volunteers, 56 patients human eotaxin. Urinary eotaxin levels were standardized by with primary or secondary glomerular diseases and two the amount of creatinine in the urine. hypereosinophilic syndrome patients without renal involvement (Table 1) . The clinical profiles of normal volunteers and patients are summarized in Table 1 . Patients with minimal change nephrotic syndrome showed massive urinary Immunohistochemical studies protein excretion (>3.5 g/day). The patients in this study were chosen randomly. There were 39 males and 43 females The presence of eotaxin protein was demonstrated immunowith a median age of 50.1 years (range 16-82 years). All histochemically on frozen tissue specimens by the indirect patients with renal diseases had the diagnosis verified by avidin-biotinylated alkaline phosphatase complex method renal biopsy. Whenever possible, patients did not receive any with a specific murine monoclonal anti-human eotaxin antiimmunosuppressive agents before the sample were collected. body (H-1) as described previously [4] . A normal mouse Patients in a clinically active state were treated with gluco-IgG, which had been absorbed with both human liver extracts corticoids including methylprednisolone pulse therapy and immunoglobulin, was used as a negative control. In (500-1000 mg/day, 3 days) during this study. All renal addition, the absorption test was performed using a monobiopsies were performed with the consent of the patients.
clonal anti-human eotaxin antibody with an excess amount of recombinant eotaxin.
Pathological studies
Fifty-six kidney specimens were obtained by renal biopsy. Two observers, without knowledge of the clinical course, examined the renal tissue under a light microscope to estab-Results lish the diagnosis using standard pathological methods.
The detection of urinary eotaxin is highly specific for the Eotaxin measurements renal interstitial eosinophilia
The urinary eotaxin levels were detected in only one
Spontaneously voided midstream urines were collected. In all cases, urines were collected in the morning of renal biopsy. patient with renal interstitial eosinophilia with memTen milliliters of the each urine was spun at 200×g for 5 min branous nephropathy ( Table 1) , while other renal at room temperature to remove cells and precipitates. Sera disease patients and healthy volunteers did not show were obtained simultaneously from patients. The urinary detectable levels of urinary eotaxin. In addition, supernatants and sera were kept frozen at −70°C until patients with hypereosinophilic syndrome without measurement. Urinary and serum eotaxin levels were deter-renal involvement, interstitial nephritis alone and memmined by enzyme-linked immunosorbent assay ( ELISA), branous nephropathy with/without interstitial nephritis using a specific murine monoclonal anti-human eotaxin did not show detectable levels of urinary eotaxin.
antibody (clone H-1) as a capture and a rabbit polyclonal Moreover, serum eotaxin levels from normal volunteers anti-eotaxin antibody as the second antibody as described and all patients, including those with hypereosinophilic previously [4] . This system is highly specific for eotaxin, since there were no cross-reactivities with other chemokines syndrome, were below the detection limit of ELISA. Clinical profile of the renal interstitial eosinophilia addition, normal mouse IgG and the absorption test showed no staining in the case with positive staining patient for eotaxin. Thus, in this case, the staining for eotaxin A 48-year-old man, suffering from nephrotic syndrome may be specific and renal interstitial infiltration of with eosinophilia and had a past history of bronchial eosinophils may have been caused by the local producasthma and atopic dermatitis in childhood, but denied tion of eotaxin. As positive controls, we used resected receiving any recent treatment. Urine analysis showed tonsils derived from the patient with allergic rhinorritis proteinuria of 4.2 g/day and microscopic hematuria and tonsillitis, since few reports reveal the detection of with granular casts. Hematological tests demonstrated in situ expression of eotaxin in human organs. leukocytosis (10 100/mm3) associated with marked eosinophilia (3030/mm3). There was moderately deterior-Effects of glucocorticoid therapy on clinical course and ated renal function as indicated by a decreased urinary eotaxin levels creatinine clearance (Ccr, 33 ml/min). Remarkable hypergammaglobulinemia was observed with a marked In this patient, the elevated urinary eotaxin levels elevation of immunoglobulin E (12 010 unit/ml ). Renal decreased dramatically during glucocorticoid treatment biopsy revealed diffuse interstitial nephritis with a including methylprednisolone pulse therapy ( Figure marked infiltration of eosinophils as well as mono-3). This treatment improved Ccr (46 ml/min) and nuclear cells and membranous nephropathy associated proteinuria (1.6 g/day) associated with the decrease in with segmental sclerotic lesions (Figure 1) . the number of eosinophils (<100/mm3) in the circulation. Re-biopsy after the therapy demonstrated a marked improvement of the interstitial nephritis and Immunohistochemical detection of eotaxin protein in the disappearance of tissue eosinophils.
renal tissue
We evaluated the presence of antigenic eotaxin protein Discussion in renal tissue. We found that eotaxin-positive cells were detected mainly in endothelial cells, infiltrating mononuclear cells in the tubulointerstitial lesions and This study revealed that urinary eotaxin was detected only in the patient with renal interstitial eosinophilia. in a small number of renal epithelial cells in immunohistochemical analysis in the patient with renal inter-We did not detect urinary eotaxin in any other patients with hypereosinophilic syndrome without renal stitial eosinophilia with membranous nephropathy. However, there was no specific staining in glomeruli involvement, membranous nephropathy with/without interstitial nephritis or interstitial nephritis alone. The (Figure 2 ). In contrast, eotaxin was hardly detected in the kidneys of the other 55 biopsy-proven renal diseases most noticeable difference between this patient and the others was the drastic infiltration of renal interstitial examined, as similarly observed in the normal part of resected kidneys of reninoma (data not shown). In eosinophils. In addition, other renal diseases examined kidney and the precise mechanism involved in renal interstitial eosinophilia via eotaxin remain to be investigated.
We detected the presence of eotaxin in endothelial cells, renal epithelial cells and infiltrating mononuclear cells in the tubulointerstitial regions in the kidney of renal interstitial eosinophilia. In addition, eotaxin was hardly detected in the other renal diseases and normal kidneys. Even though recent studies indicate that eotaxin is expressed in kidneys [2], the site of production in the kidney remains unclear. In addition, the presence of eotaxin protein in any other organ, including the lung, remains to be investigated, even though increased expression of eotaxin has been detected in bronchoalveolar lavage from asthma patients [6 ] and eotaxin mRNA has been detected in resected colons from Collectively, the existence of eotaxin in the kidney may have induced tissue eosinophilia in this patient.
Urinary levels of eotaxin decreased to undetectable here included lupus nephritis, in which increased prolevels during the convalescence induced by glucocortduction of cytokines has been reported [4] . These data icoids including methylprednisolone pulse therapy. suggest that eotaxin is highly specific for the renal Human eotaxin has been reported to be an early interstitial eosinophilia and that the up-regulation of response gene of cytokine-stimulated epithelial and eotaxin in the kidney may require some specific stimuli.
endothelial cells, and is expressed in leukocytes includMoreover, patients with minimal change nephrotic ing eosinophils [3] . Eotaxin is directly chemotactic for syndrome showed undetectable levels of urinary eoteosinophils, but not mononuclear cells or neutrophils. axin. Patients with minimal change nephrotic syndrome Thus, the specific expression of eotaxin in the tissue often show high levels of IgE, suggesting that an may play a crucial role in the tissue eosinophilia with allergic mechanism may be involved in the pathogenesis the activation of adhesion molecules. Eotaxin mRNA of minimal change nephrotic syndrome [5] . However, is up-regulated by cytokines, including IL-1, tumor our results suggest that there might be not be a necrosis factor ( TNF )-a and interferon (IFN )-c [3] . correlation between eotaxin and the pathogenesis of These cytokines are regulated by the activation of minimal change nephrotic syndrome or proteinuria itself. Thus, the specific regulator(s) of eotaxin in the nuclear factor (NF )-kB. In addition, glucocorticoids
